Tag - DPD2

Developments

Imagin Medical supports Bladder Cancer Awareness Month

This month, Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) will be undertaking a number of efforts and activities to help raise awareness about bladder cancer. Imagin has created and will...

May 12, 2020

Developments

Imagin Medical successfully completes i/Blue’s design verification

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) completed design verification of its i/Blue Imaging System functional unit on schedule. i/Blue is based on advanced optics and light sensors...

January 8, 2020

Developments

Imagin Medical updates i/Blue’s functional unit development

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) provided an update on its progress towards verifying the i/Blue imaging system’s functional prototype. The company has integrated the i/Blue...

July 15, 2019

Executive Moves

Imagin Medical adds world-renowned bladder cancer expert Dr. Ashish Kamat to SAB

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) named Dr. Ashish Kamat to its scientific advisory board.

April 17, 2019

Executive Moves

Imagin Medical names Chris Bleck to its board

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart:DPD2) named Chris Bleck to its board.

October 2, 2018

Tag - DPD2

Imagin Medical supports Bladder Cancer Awareness Month

Imagin Medical successfully completes i/Blue’s design verification

Imagin Medical updates i/Blue’s functional unit development

Imagin Medical adds world-renowned bladder cancer expert Dr. Ashish Kamat to SAB

Imagin Medical names Chris Bleck to its board

General

More